Medicinal Products For Obstructive Airway Diseases – Medicinal Products Containing Omalizumab. The Subject Of The Public Contract Is The Continuous Supply Of Medicinal Products Containing Omalizumab Until 30 December 2029 According To The Current Needs Of The Contracting Authority.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.